Comment on ESC/ CSC Guidelines
Heart rhythm disorders and comorbidities
Authors:
J. Vítovec
Authors‘ workplace:
I. interní kardioangiologická klinika LF MU a FN u sv. Anny v Brně
Published in:
Kardiol Rev Int Med 2016, 18(4): 241-245
Overview
Arrhythmias, conductance disturbances and co-morbidities are important aspects of care for patients with heart failure. Arrhythmias and co-morbidities and their treatments can directly influence the course of heart failure. Therefore, they are also addressed in the new (2016) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure.
Keywords:
arrhythmias – heart failure – co-morbidities
Sources
1. Ponikowski P, Voors AA, Anker D et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur Heart J 2016; 37(27): 2129 – 2200. doi: 10.1093/ eurheartj/ ehw128.
2. Špinar J, Hradec J, Špinarová L et al. Summary of the 2016 ESC Guidelines on the diagnosis and treatment of acute and chronic heart failure. Prepared by the Czech Society of Cardiology. Cor Vasa 2016; 58(5): e530 – e568.
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2016 Issue 4
-
All articles in this issue
-
Comment on ESC/CSC Guidelines
Diagnosis of heart failure -
Comment on ESC/CSC Guidelines
Heart failure pharmacotherapy -
Comment on ESC/ CSC Guidelines
Heart rhythm disorders and comorbidities -
Comments on ESC/ CSC Guidelines
Acute heart failure - Long-term left ventricular assist devices in heart failure treatment
- MicroRNA in cardiology – review for clinical practice
- Application of molecular diagnostics of cardiomyopathies in paediatric practice
- Iron and atherosclerosis
- Treatment of hypertension in older patients
- Dual inhibition of the angiotensin receptor and neprilysin – revolutionary principle of treatment of chronic heart failure with reduced left ventricular ejection fraction
- Lipertance® – two problems, one solution
-
Comment on ESC/CSC Guidelines
- Cardiology Review
- Journal archive
- Current issue
- About the journal
Most read in this issue
- Long-term left ventricular assist devices in heart failure treatment
-
Comment on ESC/CSC Guidelines
Diagnosis of heart failure - Treatment of hypertension in older patients
- Lipertance® – two problems, one solution